| Cat. No. |
Product Name |
Information |
| PC-21880 |
GPR183 antagonist 33
GPR183 antagonist
|
GPR183 antagonist 33 is a highly potent, selective GPR183 (Epstein–Barr-virus-induced gene 2, EBI2) antagonist with IC50 of 0.83 nM in cAMP assays, and 1.83 nM in CER-reporter assays. |
| PC-21501 |
GPR183 antagonist 32
GPR183 antagonist
|
GPR183 antagonist 32 is potent, selective antagonist of GPR183 (EBI2) with IC50 of 8.6/12.1 nM (human/mouse β-arrestin), respectively. |
| PC-72118 |
GPR183 antagonist SAE-1
GPR183 antagonist
|
GPR183 antagonist SAE-14 is a potent, selective GPR183 antagonist with IC50 of 8.3 nM, inhibits calcium mobilization induced by 7α,25-OHC in HL-60 cells. |
| PC-72117 |
GPR183 antagonist SAE-14
GPR183 antagonist
|
GPR183 antagonist SAE-14 is a potent, selective GPR183 antagonist with IC50 of 28.5 nM, inhibits GPR183-dependent 7α,25-dihydroxycholesterol-induced calcium signaling in HL-60 cells. |
| PC-42985 |
NIBR189
GPR183 inhibitor
|
NIBR189 is a potent and selective EBI2 (GPR183) antagonist with IC50 of 11 and 15 nM for hEBI2 and mEBI2, respectively. |
| PC-62127 |
ML401
GPR183 inhibitor
|
ML401 (CID73169083) is a potent, functional antagonist of EBI-2 (Epstein-Barr virus-induced gene 2, GPR183) with IC50 of 1 nM, displays activity in a chemotaxis assay (IC50=6 nM). |
| PC-42332 |
GSK682753A
GPR183 inhibitor
|
GSK682753A (GSK 682753A, GSK-682753A) is a potent, selective EBI-2 (GPR183) inhibitor with IC50 of 53.6 nM. |
